Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Fluvoxamine)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST002094 AN003420 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic LC-MS
ST002094 AN003421 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic LC-MS
ST002094 AN003422 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic LC-MS
ST002089 AN003412 Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. Blood Human COPD National Jewish Health LC-MS
ST001876 AN003038 Metabolomics analysis of multiple samples on Agilent 6546-Part 2 Feces Mouse Dalian Institute Of Chemical Physics LC-MS
ST001876 AN003038 Metabolomics analysis of multiple samples on Agilent 6546-Part 2 Liver Mouse Dalian Institute Of Chemical Physics LC-MS
ST001874 AN003036 Metabolomics analysis of multiple samples on Agilent 6546-Part 1 Blood Human Dalian Institute Of Chemical Physics LC-MS
ST001874 AN003036 Metabolomics analysis of multiple samples on Agilent 6546-Part 1 Hep G2 cells Human Dalian Institute Of Chemical Physics LC-MS
ST001874 AN003036 Metabolomics analysis of multiple samples on Agilent 6546-Part 1 Urine Human Dalian Institute Of Chemical Physics LC-MS
  logo